ФИЛАДЕЛЬФИЯ. Понедельник на BIO начинается во вторник. Крупнейшее ежегодное событие для биомедицинской индустрии, которое в нынешнем году проходит в Филадельфии, по традиции стартовало с партнеринга, и только на следующий день открылась выставка участников...
Skolkovo resident startup ExoAtlet , which makes rehabilitation exoskeletons that help disabled people to walk again, has raised $5 million in investment to expand its business to Europe and beyond. The funding is being provided by the Korean company Cosmo...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
The Skolkovo Foundation has signed a cooperation agreement with Janssen, a Belgium-headquartered subdivision of U.S. pharma giant Johnson & Johnson, with the aim of boosting innovative pharmaceutical research, including through financial support. Priority...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Fourteen Skolkovo biomed startups are currently taking part in the BIO International Convention 2017 in San Diego, California. The four-day convention, which began on June 19, is devoted to the research and development of innovative healthcare, agricultural...